Mark Vishnepolsky MD FACP, FASN
Acute Renal Failure, Chronic Renal Failure & Dialysis, Glomerular Disease, Hereditary Kidney Disease Genetics
Nephrologist
Join to View Full Profile
1294 S Jones BlvdLas Vegas, NV 89146
Phone+1 702-877-1887
Fax+1 702-877-4536
Dr. Vishnepolsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mark Vishnepolsky is a nephrologist based in Las Vegas, NV, specializing in acute and chronic renal failure, dialysis, glomerular disease, and hereditary kidney disease genetics. He completed his fellowship in nephrology at the National Capital Consortium, and holds an MD from Ohio State University College of Medicine, along with an MBA and MSF from Northeastern University. Dr. Vishnepolsky has been the Chief of Nephrology at Mike O'Callaghan Federal Hospital since 2008 and an partner at KSOSN since 2012. He has published research in major journals, including works on roxadustat and colistin-related nephrotoxicity. His professional honors include fellowship designations from the American Society of Nephrology and the American College of Physicians.
Education & Training
Northeastern UniversityMSF, 2021 - 2022- Northeastern University MBA, 2019 - 2021
National Capital Consortium (Walter Reed)Fellowship, Nephrology, 2006 - 2008
San Antonio Uniformed Services Health Education ConsortiumResidency, Internal Medicine, 2003 - 2006
Ohio State University College of MedicineClass of 2003
Certifications & Licensure
NV State Medical License 2008 - 2025
VA State Medical License 2004 - 2014
American Board of Internal Medicine Nephrology
National Board of Physicians and Surgeons Internal Medicine- National Board of Physicians and Surgeons Nephrology
Awards, Honors, & Recognition
- Fellow (ASNF) American Society of Nephrology
- Fellow (FACP) American College of Physicians
Publications & Presentations
PubMed
- A phase 3b, multicenter, open-label, single-arm study of roxadustat (ASPEN): Operational learnings within United States dialysis organizations.Steven Fishbane, Mark Vishnepolsky, Yemmie Oluwatosin, Jacqueline Nolen, Lixia Zhu
Hemodialysis International. International Symposium on Home Hemodialysis. 2023-10-01 - 271 citationsNephrotoxicity Associated with Intravenous Colistin (Colistimethate Sodium) Treatment at a Tertiary Care Medical CenterJoshua D. Hartzell, Robert T. Neff, Julie A. Ake, Robin S. Howard, Stephen W. Olson
Clinical Infectious Diseases. 2009-06-15
Professional Memberships
- Fellow
- Fellow
- Renal Physicians AssociationMember
Other Languages
- Russian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
